A Phase 1 Study of Tumor Treating Fields in Spinal Metastasis
Recruiting Phase 1 NCT06906900
Study Description
A Study to Evaluate the Safety of Tumor Treating Fields for the Treatment of Spinal Tumors that Did Not Respond to Previous Therapy
Study Details
- Registry ID:
- NCT06906900
- Conditions:
- Spinal Metastasis
- Phase:
- Phase 1
- Target Enrollment:
- 30 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.